For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
The federal government and stakeholders interested in device innovation and evaluation should support the creation of a comprehensive partnership on medical devices to monitor the products' performance after they become commercially available, a Food and Drug Administration-initiated and independent national group of experts is recommending in a report. The recommendations call for a master network of data in each clinical area where devices are used.
